SG Healthcare
Daily close in US$ at the latest USD/KRW close. Source: KRX via FinanceDataReader.
Sghealthcare makes medical imaging equipment, devices that scan and visualise the body's organs, tissues, and cells to help doctors diagnose and treat disease.
Its products are used by hospitals and other medical institutions, and they cover both human patients and companion animals. The company is listed on KOSDAQ, South Korea's tech- and small-cap exchange.
Summary is AI-generated and may contain errors · figures from DART filings
SG Healthcare in five facts
What does SG Healthcare do?
Sghealthcare makes medical imaging equipment, devices that scan and visualise the body's organs, tissues, and cells to help doctors diagnose and treat disease.
Where is SG Healthcare listed and in which sector?
SG Healthcare (Korean name: 에스지헬스케어) trades under KRX code 398120 on KOSDAQ, the Korea Exchange's board for smaller and growth companies. It is classified in the Health Care sector, Medical Devices.
How large is SG Healthcare?
Its market capitalisation was US$21.2M on 2026-10-21, which puts it in this site's small-cap group. US$ amounts are converted from won at 1 USD ≈ ₩1,325 (2026-10-21).
What were SG Healthcare's latest annual revenue and operating profit?
For fiscal year 2025, SG Healthcare reported revenue of US$18.6M, operating profit of US$1.1M and net income of US$705.7K, per its annual report on DART (data retrieved from DART on 2026-10-02). Revenue was up 52.8% on the previous year.
Where does this data come from?
Financial statements and filings come from DART, Korea's official corporate-filing system. Share prices, market capitalisation and trading status come from KRX. Company summaries are AI-generated from the filings and may contain errors; financial figures are mapped directly from DART.
Data sources and last updated
- Filings and financial statements
- DART (dart.fss.or.kr), Korea's official corporate-filing system
- Prices, market cap, trading status
- KRX (Korea Exchange), via FinanceDataReader
- Latest annual financials
- Fiscal year 2025, data retrieved from DART on 2026-10-02
- Share price and market cap
- Close of 2026-10-21
- Currency
- US$, converted from won at 1 USD ≈ ₩1,325 (2026-10-21 close)
- Company data updated
- 2026-10-21
- Company summary
- AI-generated from filings; may contain errors. Information only, not investment advice.
- Half-year report (2026.06)Aug 31
- [Amended] Supply contract signed
Sghealthcare amended its previously disclosed medical equipment supply contract in Uzbekistan (confirmed contract amount US$1.24M, 10.6% of recent revenue), extending the end date from 2026-08-31 to 2026-10-31 due to a delay in the local inspection schedule.
Supply contract · Aug 26 - [Amended] Supply contract signed
Sghealthcare amended its previously disclosed medical equipment supply contract in Uzbekistan (confirmed contract amount US$9.08M, 78% of recent revenue), extending the end date from 2026-08-31 to 2026-10-31 due to a delay in the local inspection schedule.
Supply contract · Aug 26 - [Amended] Supply contract signed (voluntary)
SG Healthcare updated a previously disclosed supply contract with PLOUTOS TRADELINK PTE. LTD., now worth US$537K, about 5.4% of its recent annual revenue, running through Jul 2026.
Supply contract · Jul 24 - [Amended] Supply contract signed (voluntary)
SG Healthcare updated a previously disclosed supply contract with PLOUTOS TRADELINK PTE. LTD., now worth US$525K, about 5.4% of its recent annual revenue, running through Jul 2026.
Supply contract · Jul 10 - [Amended] Supply contract signed (voluntary)
SG Healthcare updated a previously disclosed supply contract with PLOUTOS TRADELINK PTE. LTD., now worth US$511K, about 5.4% of its recent annual revenue, running through Jul 2026.
Supply contract · Jun 25 - [Amended] Supply contract signedSupply contract · Jun 25
- [Amended] Supply contract signedSupply contract · May 26
- [Amended] Supply contract signedSupply contract · Mar 27
- Change of 30% or more in revenue or profit/loss structure (15% for large companies)
SG Healthcare reported consolidated results for FY2025: revenue of US$17.4M (+58.3% year on year), operating profit of US$1.07M (from a loss a year earlier) and net income of US$946K (from a loss a year earlier).
Earnings · Feb 9 - [Amended] Supply contract signed (voluntary)
SG Healthcare updated a previously disclosed supply contract with PLOUTOS TRADELINK PTE. LTD., now worth US$546K, about 5.4% of its recent annual revenue, running through Jun 2026.
Supply contract · Feb 2